July 16, 2021Open Access
Rehabilitation Using Mobile Health for Older Adults With Ischemic Heart Disease in the Home Setting (RESILIENT): Protocol for a Randomized Controlled Trial (Preprint)
Key result
The RESILIENT trial is an ongoing randomized protocol aiming to enroll 400 older adults with ischemic heart disease to evaluate the efficacy of mobile health cardiac rehabilitation on functional mobility.
Why the study?
Participation in cardiac rehabilitation remains low among older adults, and efficacy data for mobile health cardiac rehabilitation are currently lacking.
Does mobile health cardiac rehabilitation improve functional mobility in older adults with ischemic heart disease?
Population
Target 400 patients aged ≥65 years with ischemic heart disease
Comparison
mHealth-CR vs usual care
Design
Multicenter 3:1 randomized clinical trial protocol
Follow-up
3 months
Authors
Discussion
Loading...
Member takes
Implication
Tests mHealth-CR feasibility in older adults with IHD where uptake is low; RCT will deliver first efficacy data to guide adoption.
Study Design
Type
RCT (n=400)
Randomization
3:1
Multicenter
Yes
Structured PICO
Does mobile health cardiac rehabilitation improve functional mobility in older adults with ischemic heart disease?
P
Population
400 older adults (aged ≥65 years) with ischemic heart disease randomized to mobile health cardiac rehabilitation or usual care, with a 3-month follow-up.
I
Intervention
Mobile health cardiac rehabilitation (mHealth-CR) consisting of a commercially available mobile health software platform coupled with weekly exercise therapist sessions
C
Comparator
Usual care
O
Outcome
Change in functional mobility (6-minute walk distance) measured at baseline and 3 monthssurrogate
The RESILIENT trial protocol outlines a study to evaluate the efficacy of a mobile health cardiac rehabilitation program on functional mobility in older adults with ischemic heart disease.
Cite This Study
Dodson et al. (2021) conducted an RCT in Ischemic heart disease (n=400). Mobile health cardiac rehabilitation (mHealth-CR) vs. Usual care was evaluated on Change in functional mobility (6-minute walk distance). The RESILIENT trial is an ongoing randomized protocol aiming to enroll 400 older adults with ischemic heart disease to evaluate the efficacy of mobile health cardiac rehabilitation on functional mobility.